z-logo
open-access-imgOpen Access
ATP scavenging by the intracellular pathogen Porphyromonas gingivalis inhibits P2X 7 ‐mediated host‐cell apoptosis
Author(s) -
Yilmaz Özlem,
Yao Luyu,
Maeda Kazuhiko,
Rose Timothy M.,
Lewis Emma L.,
Duman Memed,
Lamont Richard J.,
Ojcius David M.
Publication year - 2008
Publication title -
cellular microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.542
H-Index - 138
eISSN - 1462-5822
pISSN - 1462-5814
DOI - 10.1111/j.1462-5822.2007.01089.x
Subject(s) - biology , porphyromonas gingivalis , intracellular , purinergic receptor , extracellular , microbiology and biotechnology , apoptosis , programmed cell death , secretion , innate immune system , receptor , biochemistry , bacteria , genetics
Summary The purinergic receptor P2X 7 is involved in cell death, inhibition of intracellular infection and secretion of inflammatory cytokines. The role of the P2X 7 receptor in bacterial infection has been primarily established in macrophages. Here we show that primary gingival epithelial cells, an important component of the oral innate immune response, also express functional P2X 7 and are sensitive to ATP‐induced apoptosis. Porphyromonas gingivalis, an intracellular bacterium and successful colonizer of oral tissues, can inhibit gingival epithelial cell apoptosis induced by ATP ligation of P2X 7 receptors. A P. gingivalis homologue of nucleoside diphosphate kinase (NDK), an ATP‐consuming enzyme, is secreted extracellularly and is required for maximal suppression of apoptosis. An ndk ‐deficient mutant was unable to prevent ATP‐induced host‐cell death nor plasma membrane permeabilization in the epithelial cells. Treatment with purified recombinant NDK inhibited ATP‐mediated host‐cell plasma membrane permeabilization in a dose‐dependent manner. Therefore, NDK promotes survival of host cells by hydrolysing extracellular ATP and preventing apoptosis‐mediated through P2X 7 .

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here